Clinical Trial Update: A Phase I/II Study of BGT226 in Adult Patients With Advanced Solid Malignancies Including Patients With Advanced Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II trial update for BGT226 in adults with advanced solid malignancies including breast cancer; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Cowden Syndrome
• Solid Tumors

Drugs mentioned

• BGT226

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Solid Tumors, Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED